“Alert: Ozempic Label Updated with New Gastrointestinal Side Effect Warning from FDA”
FDA Enhances Safety Information for Ozempic with New Gastrointestinal Side Effect Warning March 15, 2022 The FDA’s Latest Update The Food and Drug Administration (FDA) has recently announced an important update to the label of the diabetes medication Ozempic (semaglutide). The agency is adding a new warning about potential gastrointestinal side effects to the label … Read more